First Header Logo Second Header Logo

Connection

Gennadiy Moiseyev to Retinaldehyde

This is a "connection" page, showing publications Gennadiy Moiseyev has written about Retinaldehyde.
Connection Strength

0.974
  1. Malechka VV, Chen J, Cheng R, Ma JX, Moiseyev G. The Single Administration of a Chromophore Alleviates Neural Defects in Diabetic Retinopathy. Am J Pathol. 2020 Jul; 190(7):1505-1512.
    View in: PubMed
    Score: 0.722
  2. Wang Y, Ma X, Muthuraman P, Raja A, Jayaraman A, Petrukhin K, Cioffi CL, Ma JX, Moiseyev G. The novel visual cycle inhibitor (±)-RPE65-61 protects retinal photoreceptors from light-induced degeneration. PLoS One. 2022; 17(10):e0269437.
    View in: PubMed
    Score: 0.215
  3. Malechka VV, Moiseyev G, Takahashi Y, Shin Y, Ma JX. Impaired Rhodopsin Generation in the Rat Model of Diabetic Retinopathy. Am J Pathol. 2017 Oct; 187(10):2222-2231.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.